PTPN6 and bladder transitional cell carcinoma: PTPN6 may improve the chemotherapy efficacy and can be used in combination with blocking antibodies in immunotherapy; moreover, some studies suggest that PTPN6 may be an immune-related prognostic biomarker for BLCA (Shen et al., 2020).